ERJ Open Research
Impact of Simeox ® Device in Bronchiectasis Patients: a quasi-experimental study
By Lucía Méndez, Cristina Alves, Cristiana Cruz and 9 others.
Abstract
Extract Bronchiectasis is a chronic lung disease characterized by abnormal and irreversible dilatation of the bronchi, leading to excessive mucus accumulation, recurrent infections, and progressive lung damage. Impaired mucociliary clearance exacerbates disease progression and reduces quality of life (QoL) [1]. Airway clearance techniques (ACTs), including oscillating devices like Simeox®, are a core component of bronchiectasis management [2–4]. However, real-world data indicate that airway clearance management is not consistently implemented in clinical practice [5].



